U.S. Dialysis Services Market - By Type (Hemodialysis, Peritoneal Dialysis), By Service (Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis) & Forecast, 2024 – 2032

U.S. Dialysis Services Market Size

U.S. Dialysis Services Market was valued at USD 33.7 billion in 2023 and is expected to exhibit growth at a CAGR of 4% from the 2024 – 2032. This market growth can be attributed to favorable reimbursement scenarios available for dialysis treatment, increasing awareness and education, and a rise in R&D investment.
 

The favorable reimbursement landscape, particularly through government programs like Medicare and Medicaid in the U.S., significantly influences the adoption of dialysis treatment. For instance, according to a study published by the JAMA Network in 2021, 80% of U.S. patients who received dialysis for end-stage kidney disease (ESKD) had Medicare as their primary payer. Medicare and Medicaid coverage for dialysis procedures alleviate the financial burden on patients, making it more affordable for them to receive ongoing treatment. This encourages patients to adhere to prescribed dialysis regimens and reduces the risk of treatment discontinuation due to cost barriers.
 

Additionally, increased R&D investment is continuously fostering innovation in dialysis technology and treatment modalities, leading to the development of advanced dialysis treatment options. These innovations aim to enhance treatment efficacy, patient comfort, and overall outcomes in dialysis therapy. By investing in R&D, companies introduce novel solutions that address unmet clinical needs and improve the delivery of dialysis services in the U.S. This focus on innovation drives product differentiation, expands market opportunities, and fosters competitiveness, thus driving further market expansion.
 

Dialysis services refer to a range of medical procedures and treatments designed to support individuals with impaired kidney function or end stage renal disease (ESRD). These services encompass various modalities, including hemodialysis and peritoneal dialysis, which aim to remove waste products, excess fluids, and toxins from the blood when the kidneys are unable to perform these functions adequately.
 

U.S. Dialysis Services Market Trends

• The prevalence of end-stage renal disease (ESRD) is on the rise in the U.S., primarily due to factors such as an aging population, a higher incidence of chronic conditions like diabetes and hypertension, and improved survival rates for patients with kidney diseases. For instance, according to NIH data, in 2022, around 808,000 people in the U.S. were suffering from end-stage renal disease, and this number is expected to increase in the near future. As the number of individuals diagnosed with ESRD increases, so does the demand for dialysis services to manage their condition.
   
• Moreover, the aging population is more susceptible to chronic kidney diseases (CKD) and ESRD. As people age, their kidneys may naturally decline in function, leading to the development of kidney diseases. Additionally, older adults are more likely to have comorbidities such as diabetes and hypertension, which further increase their risk of developing ESRD. The demographic shift toward an older population contributes to the growing demand for dialysis services.
   
• Furthermore, efforts to improve access to healthcare, including preventive services, early detection, and treatment for kidney diseases, contribute to the diagnosis of ESRD at earlier stages. Early intervention and timely initiation of dialysis therapy help manage the progression of kidney failure and improve patient outcomes. Increased access to healthcare services ensures that ESRD patients receive the necessary dialysis treatments, thereby fueling the growth of the dialysis services market.
   

U.S. Dialysis Services Market Analysis

Based on type, the market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the market in 2023 with a revenue of USD 29.3 billion.
 

• The increasing instances of chronic kidney disorders and end-stage renal disease have heightened the burden of renal disorders. According to a recent report from the Centers for Disease Control and Prevention (CDC), around 15% of adults in the U.S. are suffering from chronic kidney disease (CKD), and over 360 patients prepare to undergo dialysis for kidney failure every 24 hours.
   
• Hemodialysis is the most commonly used modality for dialysis treatment in the U.S. It involves filtering blood through an artificial kidney (dialyzer) to remove waste products and excess fluid. The widespread adoption of hemodialysis is attributed to its effectiveness in managing end-stage renal disease (ESRD) and its availability in various healthcare settings, including dialysis centers, hospitals, and even home-based settings.
   
• Additionally, the U.S. healthcare system has a well-established infrastructure to support hemodialysis services. Dialysis centers equipped with hemodialysis equipment, trained staff, and medical resources are widely accessible across the country. This infrastructure facilitates the delivery of hemodialysis treatments to a large patient population, contributing to its dominant market share.
   

Based on service, the U.S. dialysis services market is classified into acute dialysis and chronic dialysis. The chronic dialysis segment held a substantial market revenue of USD 27.1 billion in 2023.
 

• Patients with ESRD typically require long-term or lifelong dialysis treatment to manage their condition effectively. Chronic dialysis involves regular, scheduled sessions, usually multiple times per week, to remove waste products and excess fluids from the bloodstream. This ongoing treatment regimen ensures that patients receive the necessary renal support to maintain their health and well-being.
   
• Furthermore, chronic dialysis services are delivered in specialized healthcare settings staffed by multidisciplinary teams of nephrologists, nurses, technicians, and other healthcare professionals with expertise in renal care. These teams provide comprehensive clinical management, monitoring, and supportive care to patients undergoing chronic dialysis, ensuring optimal treatment outcomes and patient well-being, and contributing to the widespread adoption of these services.

Based on end-use, the U.S. dialysis services market is segmented into in-center dialysis and home dialysis. The in-center dialysis segment dominated the market in 2023 and is anticipated to reach USD 38.6 billion by 2032.
 

• Dialysis centers are equipped with advanced dialysis machines and medical professionals specializing in renal care. This access to specialized equipment and staff enhances the quality of care provided to patients, leading to better treatment outcomes and providing reassurance for patients and their families.
   
• Furthermore, in-center dialysis facilities offer a structured and controlled environment for patients during their treatment sessions. The clinical setting provides a sense of security and familiarity for patients, allowing them to feel comfortable and relaxed during their dialysis treatments.
   
• In-center dialysis is typically covered by insurance plans, including Medicare and private insurance. This coverage makes it an accessible option for many patients, eliminating financial barriers to treatment and increasing its preference among individuals with end-stage renal disease (ESRD).
   
• As a result, the in-center segment is poised to maintain its high market share in the market, driving continued innovation and adoption of dialysis services.

The South Atlantic zone held a dominant position in the U.S. dialysis services market, with a revenue of USD 7.7 billion in 2023.
 

• The high market share in the South Atlantic zone can be attributed to several factors, including the presence of key market players, a robust research and development infrastructure, significant government funding for dialysis research, and a high adoption rate of advanced technologies in the healthcare sector.
   
• Additionally, high healthcare expenditure and insurance coverage contribute to the accessibility and affordability of dialysis services and treatments for patients in the South Atlantic zone.
   

North East zone exhibits a high growth potential in the U.S. dialysis services market.
 

• North East zone is a leading market for dialysis services in the U.S., with a strong healthcare system and high standards of care.
   
• The increasing demand for dialysis in several states of the North East zone can be attributed to factors such as improved awareness, the need for effective disease management, the convenience of home dialysis, aging population, government support, and technological advancements.
   
• Additionally, the increasing prevalence of ESRD and the growing demand for personalized medicine in North East region contribute to the expansion of dialysis services.
   

The Mountain States dialysis services market is expected to exhibit the fastest growth over the forecast period.
 

• Contributing factors include the growing incidence of diabetes, hypertension, obesity, and aging populations. These conditions gradually impair kidney function over time, leading to CKD.
   
• Moreover, efforts to promote kidney health in the region are improving access to screening and early detection, thereby mitigating the burden of renal disorders on individuals and society and significantly contributing to market growth.
   

U.S. Dialysis Services Market Share

The U.S. dialysis services industry is characterized by the presence of several key players offering innovative products. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their service portfolios, and gain a competitive advantage.
 

U.S. Dialysis Services Market Companies

Prominent players operating in the U.S. dialysis services industry include:

• Baxter International Inc.
• Centers for Dialysis Care
• DaVita Inc.
• Dialysis Clinic, Inc.
• Fresenius Medical Care
• Innovative Renal Care
• Rogosin Institute
• Sanderling Renal Services
• Satellite Healthcare
• U.S. Renal Care, Inc.
   

U.S. Dialysis Services Industry News:

• In April 2023, DaVita Inc. and Medtronic plc collaboratively announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions. This strategic move helped the company focus on and serve patients with kidney disease.
   
• In May 2022, Sanderling Renal Services, Inc. announced a strategic partnership with Pharos Capital Group, LLC, to enhance their dialysis and renal care services in remote locations across the U.S. This partnership helped the company enhance its home dialysis operations and improve its business operations, thus strengthening its market position.
   

The U.S. dialysis services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hemodialysis
• Peritoneal dialysis

Market, By Service

• Acute dialysis
• Chronic dialysis

Market, By End-use

• In-center dialysis
• Home dialysis

The above information is provided for the following zones and states:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin 
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• North East
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming